C4 Therapeutics (CCCC) Other Gross PP&E Adjustments: 2019-2025
Historic Other Gross PP&E Adjustments for C4 Therapeutics (CCCC) over the last 5 years, with Sep 2025 value amounting to -$26.4 million.
- C4 Therapeutics' Other Gross PP&E Adjustments rose 40.06% to -$26.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$159.4 million, marking a year-over-year increase of 18.44%. This contributed to the annual value of -$53.5 million for FY2024, which is 8.02% up from last year.
- Latest data reveals that C4 Therapeutics reported Other Gross PP&E Adjustments of -$26.4 million as of Q3 2025, which was up 31.64% from -$38.7 million recorded in Q2 2025.
- C4 Therapeutics' 5-year Other Gross PP&E Adjustments high stood at -$3.1 million for Q3 2021, and its period low was -$65.6 million during Q1 2022.
- In the last 3 years, C4 Therapeutics' Other Gross PP&E Adjustments had a median value of -$47.5 million in 2024 and averaged -$46.3 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first soared by 51.19% in 2021, then slumped by 1,735.26% in 2022.
- Over the past 5 years, C4 Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at -$25.6 million in 2021, then tumbled by 137.88% to -$60.9 million in 2022, then climbed by 4.54% to -$58.1 million in 2023, then climbed by 8.02% to -$53.5 million in 2024, then soared by 40.06% to -$26.4 million in 2025.
- Its Other Gross PP&E Adjustments was -$26.4 million in Q3 2025, compared to -$38.7 million in Q2 2025 and -$40.8 million in Q1 2025.